1.上海中医药大学附属曙光医院(上海 201203)
叶青艳,女,博士,主治医师,主要从事中西医结合治疗儿科疾病的临床研究
周华,主任医师、教授,博士生导师;E-mail: zhouhuam@163.com
扫 描 看 全 文
叶青艳,赵鋆,沈健等.藿香正气散加减治疗儿童寒湿型急性诺如病毒胃肠炎的临床疗效观察[J].上海中医药大学学报,2022,36(S1):68-71.
YE Qingyan,ZHAO Jun,SHEN Jian,et al.Clinical efficacy observation of modified Huoxiang Zhengqi Powder on acute norovirus gastroenteritis of cold⁃damp type in children[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(S1):68-71.
叶青艳,赵鋆,沈健等.藿香正气散加减治疗儿童寒湿型急性诺如病毒胃肠炎的临床疗效观察[J].上海中医药大学学报,2022,36(S1):68-71. DOI: 10.16306/j.1008-861x.2022.S1.017.
YE Qingyan,ZHAO Jun,SHEN Jian,et al.Clinical efficacy observation of modified Huoxiang Zhengqi Powder on acute norovirus gastroenteritis of cold⁃damp type in children[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(S1):68-71. DOI: 10.16306/j.1008-861x.2022.S1.017.
目的,2,评价藿香正气散加减联合西医常规疗法治疗儿童寒湿型急性诺如病毒胃肠炎的临床疗效及对血清炎性因子的影响。,方法,2,纳入寒湿型急性诺如病毒胃肠炎患儿64例,随机分为观察组和对照组,每组各32例。对照组患儿给予西医基础治疗,观察组患儿在对照组治疗基础上加用藿香正气散加减口服。两组疗程均为5 d。比较两组的临床疗效及主症消失时间;治疗前后,比较两组患儿的中医证候积分及血清白介素(IL)-6、IL-1β的水平。,结果,2,①治疗后,观察组、对照组的临床总有效率分别为93.55%、73.33%,观察组的疗效优于对照组(,P,<,0.05)。②治疗期间,观察组患儿的腹泻、恶心呕吐消失时间较对照组均明显缩短(,P,<,0.05)。③治疗后,两组患儿的中医证候积分较治疗前均降低(,P,<,0.05),且观察组患儿的积分低于对照组(,P,<,0.05)。④治疗后,两组患儿的血清IL-6、IL-1β水平较治疗前均明显降低(,P,<,0.05),且观察组患儿的IL-1β水平低于对照组(,P,<,0.05)。,结论,2,藿香正气散加减结合西医常规疗法治疗儿童寒湿型急性诺如病毒胃肠炎,能够有效改善患儿的临床症状,降低其血清炎性因子水平。
Objective: To evaluate the clinical curative effect of Huoxiang Zhengqi Powder combined with conventional western medicine on acute norovirus gastroenteritis of cold-damp type and its influence on serum inflammatory factors.,Method,2,Sixty-four children with acute norovirus gastroenteritis of cold-damp type were selected and randomly divided into observation group and control group, 32 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Huoxiang Zhengqi Powder on the basis of control group. The treatment course of both groups was 5 days. The clinical efficacy and the disappearance time of principal symptoms were compared between the two groups. Before treatment and after treatment, traditional Chinese medicine syndrome score, interleukin(IL)-6 and IL-1β in serum were compared between the two groups.,Results,2,①The total clinical efficacy rates of observation group and control group were 93.55% and 73.33%, respectively, and the curative effect of observation group was better than control group (,P,<,0.05). ②During the treatment, the disappearance time of diarrhea, nausea and vomiting in the observation group were significantly shorter than those of the control group (,P,<,0.05). ③After treatment, the Chinese medicine syndrome score of both groups was lower than that before treatment (,P,<,0.05), and the score in the observation group was lower than that in the control group (,P,<,0.05). The serum levels of IL-6, IL-1β in the two groups were lower than those before treatment, and the serum level of IL-1β in observation group was lower than that in the control group (,P,<,0.05).,Conclusion,2,Huoxiang Zhengqi Powder combined with conventional western medicine can effectively improve the clinical symptoms of children with acute norovirus gastroenteritis of cold-damp type, and reduce the levels of serum inflammatory factors.
诺如病毒急性感染性胃肠炎寒湿型藿香正气散中西医结合
norovirusacute infectious gastroenteritiscold-damp typeHuoxiang Zhengqi Powdercombination of Chinese and western medicine
ZHOU H, WANG S, VON SEIDLEIN L, et al. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes[J]. Front Med, 2020, 14(1): 1-7.
HOFMANN F M, OLAWUMI E, MICHAELIS M, et al. Significance of norovirus in occupational health: a review of published norovirus outbreaks in Central and Northern Europe[J]. Int Arch Occup Environ Health, 2020, 93(8): 911-923.
HAESSLER S, GRANOWITZ E V. Norovirus gastroenteritis in immunocompromised patients[J]. N Engl J Med, 2013, 368(10): 971.
SCHWARTZ S, VERGOULIDOU M, SCHREIER E, et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation[J]. Blood, 2011, 117(22): 5850-5856.
TRIVEDI T K, DESALVO T, LEE L, et al. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010[J]. JAMA, 2012, 308(16): 1668-1675.
HASSAN E, BALDRIDGE M T. Norovirus encounters in the gut: multifaceted interactions and disease outcomes[J]. Mucosal Immunol, 2019, 12(6): 1259-1267.
Karst S M, Wobus C E, Goodfellow I G, et al. Advances in norovirus biology[J]. Cell Host Microbe, 2014, 15(6): 668-680.
江载芳,申昆玲,沈颖. 诸福棠实用儿科学[M]. 8 版. 北京: 人民卫生出版社, 2015: 1385-1388.
诺如病毒感染性腹泻防治方案(试行)[J].医药导报, 2007, 26(3): 331.
郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002.
中华中医药学会. 中医儿科常见病诊疗指南[M]. 北京:中国中医药出版社,2012.
中华医学会儿科学分会消化学组,中华医学会儿科学分会感染学组,《中华儿科杂志》编辑委员会. 儿童腹泻病诊断治疗原则的专家共识[J]. 中华儿科杂志,2009, 47(8): 634-636.
国家药品监督管理局. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002: 139-143.
穆乃其, 潘月丽, 赵西斌, 等. 藿香正气散加减治疗小儿肠系膜淋巴结炎1例[J]. 河南中医,2013, 33(3): 436-437.
曾昊林, 李京. 藿香正气散应用简况[J]. 实用中医内科杂志, 2014, 28(8): 124-126.
罗尧岳, 龙景文, 王宇星, 等. 超微藿香正气散对急性腹泻大鼠肠黏膜保护及水电解质的调节作用研究[J]. 湖南中医药大学学报,2011, 31(5): 16-19.
谢肄聪, 唐方. 藿香正气软胶囊对肠屏障功能保护作用的机理研究[J]. 中国中药杂志,2004, 29(5): 456-458.
陆蔚, 吴文金. 藿香正气方药理研究进展[J]. 中国中医药信息杂志,2008, 15(S1): 82-83.
杜江滨, 王健, 蔡泽波. 血清降钙素原及IL-6、IL-8在急性胃肠炎患儿中的检测意义[J]. 胃肠病学和肝病学杂志,2014, 23(9): 1015-1017.
0
浏览量
305
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构